Enthera Pharmaceuticals Initiates Phase 1 Clinical Trial with Lead Candidate Ent001
Phase 1 study in healthy volunteers lays groundwork for Ent001 evaluation in patients with inflammatory bowel disease and type 1 diabetes Milan, Italy, March 7, 2023 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions, today announces the start of a Phase 1 first-in-human (FIH) clinical trial with its lead […]